Detalhe da pesquisa
1.
Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection.
Intensive Care Med
; 34(12): 2169-75, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18712349
2.
Colistin susceptibility testing by Etest and disk diffusion methods.
Int J Antimicrob Agents
; 31(5): 434-9, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18328674
3.
Epidemiology and molecular characterisation of metallo-ß-lactamase-producing Enterobacteriaceae in a university hospital Intensive Care Unit in Greece.
Int J Antimicrob Agents
; 38(5): 390-7, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-21873034
4.
Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis.
J Crit Care
; 26(3): 331.e1-7, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20869839
5.
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.
J Antimicrob Chemother
; 59(4): 786-90, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17307769
6.
Molecular characterization of an Escherichia coli clinical isolate that produces both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase GES-7: identification of the In8 integron carrying the blaVIM-2 gene.
J Antimicrob Chemother
; 58(2): 432-3, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16751200
7.
In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.
Antimicrob Agents Chemother
; 50(9): 3166-9, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16940120
8.
Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece.
J Antimicrob Chemother
; 59(3): 578-9, 2007 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17255145